Tom Inglesby
#83,869
Most Influential Person Now
Researcher, American epidemiologist, ORCID 0000-0001-5845-4732
Tom Inglesby's AcademicInfluence.com Rankings
Tom Inglesbymedical Degrees
Medical
#1779
World Rank
#2155
Historical Rank
Public Health
#270
World Rank
#279
Historical Rank
Epidemiology
#796
World Rank
#831
Historical Rank

Download Badge
Medical
Tom Inglesby's Degrees
- Masters Public Health Johns Hopkins University
Why Is Tom Inglesby Influential?
(Suggest an Edit or Addition)According to Wikipedia, Thomas Vincent Inglesby Jr. is an American epidemiologist. He is the Director of the Johns Hopkins Center for Health Security at the Johns Hopkins Bloomberg School of Public Health. Early life and education Inglesby earned his Bachelor of Arts degree from Georgetown University in 1988 and his medical degree from Columbia University Vagelos College of Physicians and Surgeons in 1992. He then completed his residency and fellowship in infectious diseases at Johns Hopkins School of Medicine.
Tom Inglesby's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Botulinum toxin as a biological weapon: medical and public health management. (2001) (1651)
- Tularemia as a biological weapon: medical and public health management. (2001) (1343)
- Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. (1999) (1148)
- Anthrax as a biological weapon, 2002: updated recommendations for management. (2002) (986)
- Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. (2000) (953)
- Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. (1999) (935)
- Hemorrhagic fever viruses as biological weapons: medical and public health management. (2002) (671)
- Priorities for the US Health Community Responding to COVID-19. (2020) (228)
- A plague on your city: observations from TOPOFF. (2001) (185)
- Death due to bioterrorism-related inhalational anthrax: report of 2 patients. (2001) (179)
- Large-scale quarantine following biological terrorism in the United States: scientific examination, logistic and legal limits, and possible consequences. (2001) (176)
- Shining light on "Dark Winter". (2002) (167)
- Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: Recommendations of the Working Group on Emergency Mass Critical Care‡ (2005) (166)
- Management of anthrax. (2002) (125)
- Public Health Measures and the Reproduction Number of SARS-CoV-2. (2020) (114)
- Disease mitigation measures in the control of pandemic influenza. (2006) (106)
- A prospective, community‐based evaluation of liver enzymes in individuals with hepatitis C after drug use (1999) (98)
- Botulinum toxin as a biological weapon (2001) (97)
- Prescription drug use and self-prescription among resident physicians. (1998) (95)
- Public health and medical responses to the 1957-58 influenza pandemic. (2009) (92)
- Anthrax 2001: observations on the medical and public health response. (2003) (86)
- Tularemia as a biological weapon (2001) (82)
- Antimicrobial resistance is a global health emergency. (2015) (81)
- Systemic collapse: Medical care in the aftermath of Hurricane Katrina. (2006) (81)
- Challenges to global surveillance and response to infectious disease outbreaks of international importance. (2007) (77)
- A Novel International Monkeypox Outbreak (2022) (67)
- Current Topics in Microbiology and Immunology (1985) (65)
- Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool (2019) (64)
- Statement on Scientific Publication and Security (2003) (55)
- Implications of Pandemic Influenza for Bioterrorism Response (54)
- COPEWELL: A Conceptual Framework and System Dynamics Model for Predicting Community Functioning and Resilience After Disasters (2017) (52)
- Hospital preparedness for pandemic influenza. (2006) (51)
- Abnormal fibrinolysis in familial pulmonary hypertension. (1973) (47)
- Regional approaches to hospital preparedness. (2007) (47)
- Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens (2014) (46)
- Global Catastrophic Biological Risks: Toward a Working Definition (2017) (45)
- Smallpox vaccination in 2003: key information for clinicians. (2003) (44)
- The prospect of using alternative medical care facilities in an influenza pandemic. (2006) (43)
- Healthcare coalitions: the new foundation for national healthcare preparedness and response for catastrophic health emergencies. (2009) (42)
- Biosecurity: responsible stewardship of bioscience in an age of catastrophic terrorism. (2003) (41)
- Aneurysms of All Sinuses of Valsalva in Patients with Marfan's Syndrome: An Unusual Late Complication Following Replacement of Aortic Valve and Ascending Aorta for Aortic Regurgitation and Fusiform Aneurysm of Ascending Aorta (1971) (41)
- The national disaster medical system: past, present, and suggestions for the future. (2007) (41)
- Statement on the consideration of biodefence and biosecurity (2003) (41)
- Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. A decade in biosecurity. Introduction. (2012) (39)
- Progress in disaster planning and preparedness since 2001. (2011) (38)
- Anthrax: A possible case history. (1999) (36)
- Challenges and Opportunities of Nontraditional Approaches to Treating Bacterial Infections (2017) (35)
- Clinical management of potential bioterrorism-related conditions. (2015) (35)
- Preventing the use of biological weapons: improving response should prevention fail. (2000) (33)
- Response of the renal vascular bed to acute experimental coronary arterial occlusion. (1972) (33)
- Death Due to Bioterrorism-Related Inhalational Anthrax (2001) (32)
- COVID-19 vaccines: early success and remaining challenges (2020) (30)
- Maximizing state and local medical countermeasure stockpile investments through the Shelf-Life Extension Program. (2009) (30)
- Uncensored exchange of scientific results (2003) (29)
- Reflex, systemic, and local hemodynamic alterations with experimental hyperosmolality. (1973) (27)
- ST-segment elevation, transient left-posterior hemiblock, and recurrent ventricular arrhythmias unassociated with pain. A variant of Prinzmetal's anginal syndrome. (1973) (27)
- Navigating the storm: report and recommendations from the Atlantic Storm exercise. (2005) (25)
- Assessment of serosurveys for H5N1. (2013) (24)
- Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic (2020) (24)
- Characteristics of Microbes Most Likely to Cause Pandemics and Global Catastrophes (2019) (24)
- Improving performance of HVAC systems to reduce exposure to aerosolized infectious agents in buildings; recommendations to reduce risks posed by biological attacks. (2006) (23)
- Biodefense R&D: anticipating future threats, establishing a strategic environment. (2003) (23)
- Taking the measure of countermeasures: leaders' views on the nation's capacity to develop biodefense countermeasures. (2004) (22)
- Public Health Principles for a Phased Reopening During COVID-19: Guidance for Governors (2020) (20)
- Working Group on Pandemic Influenza Preparedness: joint statement in response to Department of Health and Human Services Pandemic Influenza Plan. (2006) (20)
- High-containment biodefense research laboratories: meeting report and center recommendations. (2007) (19)
- Moving ahead on the global health security agenda. (2014) (17)
- A Primer on Ebola for Clinicians (2014) (16)
- Rethinking Smallpox (2004) (14)
- Preinfarction angina pectoris. A surgical emergency. (1973) (14)
- Travel bans will increase the damage wrought by ebola. (2014) (13)
- The risk of engineering a highly transmissible H5N1 virus. (2012) (13)
- Reply to “Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited” (2015) (13)
- Biomedical Advanced Research and Development Authority (BARDA) roundtable. (2007) (13)
- Cardiovascular reflexes induced by selectively altering pulmonary arterial osmolality. (1972) (12)
- Flexible defenses roundtable meeting: promoting the strategic innovation of medical countermeasures. (2007) (12)
- After Fukushima: managing the consequences of a radiological release. (2012) (12)
- Pneumocystis carinii infection of the small intestine. (1998) (12)
- Protecting the Nation from Health Security Threats (2017) (11)
- The biosecurity benefits of genetic engineering attribution (2020) (11)
- Epidemic response scenario: decision making in a time of plague. (2001) (11)
- Ramping Up the Response to Ebola. (2018) (10)
- Building the global vaccine manufacturing capacity needed to respond to pandemics (2021) (10)
- Engineered H5N1: A Rare Time for Restraint in Science (2012) (10)
- Biosurveillance where it happens: state and local capabilities and needs. (2011) (10)
- Epidemic Response Scenario: Decision Making in a Time of Plague (2001) (9)
- Design of the national health security preparedness index. (2014) (9)
- Horsepox and the need for a new norm, more transparency, and stronger oversight for experiments that pose pandemic risks (2018) (8)
- Meeting Report Hospital Preparedness for Pandemic Influenza (2006) (8)
- Public health preparedness research. (2013) (8)
- Strategic priorities for U.S. biosecurity. (2009) (8)
- Facing the biological weapons threat (2000) (8)
- Clade X: A Pandemic Exercise. (2019) (7)
- Bulls, Bears, and Birds: Preparing the Financial Industry for an Avian Influenza Pandemic. (2005) (7)
- Roundtable discussion: corporate pandemic preparedness. (2007) (7)
- Straight talk with...Tom Inglesby (2013) (7)
- COVID-19 and the US Criminal Justice System: Evidence for Public Health Measures to Reduce Risk (2020) (6)
- Pathogens as Weapons (2004) (6)
- Strengthening Security for Gene Synthesis: Recommendations for Governance. (2019) (6)
- The importance of establishing a national health security preparedness index. (2013) (5)
- How likely is it that biological agents will be used deliberately to cause widespread harm? (2016) (5)
- Toward biosecurity. (2003) (5)
- Reflex regulation of peripheral blood flow during lung hyperinflation (1972) (4)
- The Importance of Continued US Investment to Sustain Momentum Toward Global Health Security. (2017) (4)
- Vaccine Platform Technologies: A Potent Tool for Emerging Infectious Disease Vaccine Development. (2020) (4)
- Observations from the Top Off exercise. (2001) (4)
- US Global Health Security Investments Improve Capacities for Infectious Disease Emergencies. (2018) (4)
- Observations from the Top off Exercise (2001) (3)
- Bioterrorism and Public Health. An Internet Resource Guide. (2002) (3)
- Recognition and treatment of anthrax [4] (multiple letters) (1999) (3)
- Executive government positions of influence in biodefense: the Bio-Plum book. (2004) (3)
- Reflex regulation of peripheral blood flow during lung hyperinflation. (1973) (3)
- Roundtable: promoting partnerships for regional healthcare preparedness and response. (2007) (3)
- Biosafety and biosecurity in the era of synthetic biology: Meeting the challenges in China and the U.S. (2019) (3)
- Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation (2020) (3)
- Bioterrorist Threats: What the Infectious Disease Community Should Know about Anthrax and Plague (2001) (3)
- Calls for Caution in Genome Engineering Should Be a Model for Similar Dialogue on Pandemic Pathogen Research (2015) (3)
- Comments from the Center for Biosecurity of UPMC on proposed revisions to federal quarantine rules. (2006) (3)
- The globalization of US medical countermeasure production and its implications for national security. (2012) (3)
- Erratum for Lipsitch and Inglesby, Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens (2015) (2)
- PROBENECID (BENEMID) INTOXICATION WITH STATUS EPILEPTICUS. (1965) (2)
- Singapore-Malaysia-Indonesia-US Dialogue on Biosecurity. (2015) (2)
- Translumbar aortography: a mechanism of injury--a method of protection. (1966) (2)
- Biosecurity and Public Health Ethics Issues Raised by Biological Threats (2019) (2)
- Pulmonary arterial and venous hypertension and left ventricular calcification of undetermined etiology. (1986) (1)
- Health security for the time ahead. (2015) (1)
- Four Steps to Building the Public Health System Needed to Cope With the Next Pandemic. (2021) (1)
- Ready for a Global Pandemic (2017) (1)
- Assessment of Serosurveys for H 5 N 1 (2013) (1)
- Jump start: accelerating government response to a national biological crisis. (2015) (1)
- Citation of Unethical Research—Reply (2002) (1)
- Singapore - US Strategic Dialogue on Biosecurity (2014) (1)
- Make pandemics lose their power (2020) (1)
- Erratum: Uncensored exchange of scientific results (Proceedings of the National Academy of Sciences (2003) 100, 4, (1464) DOI: 10.1073/pnas.0630491100) (2012) (1)
- Recognition and Treatment of Anthrax—Reply (1999) (1)
- Setting of Relatively Low Energy Outputs May Permit Implantation of a Nonthoracotomy Automatic Cardioverter Defibrillator System When High Energy Outputs Prove Ineffective (1996) (1)
- Guidelines for Treatment of Anthrax—Reply (2002) (1)
- HISTORY OF CURRENT THREAT EPIDEMIOLOGY OF ANTHRAX MICROBIOLOGY PATHOGENESIS AND CLINICAL MANIFESTATIONS DIAGNOSIS VACCINATION THERAPY INFECTION CONTROL DECONTAMINATION AUTHOR/ARTICLE INFORMATION REFERENCES INDEX OF FIGURES AND TABLES Anthrax as a Biological Weapon, 2002 Updated Recommendations for M (2002) (1)
- National Action Plan for Expanding and Adapting the Healthcare System for the Duration of the COVID Pandemic (2020) (0)
- Final Report to PASCC: Improving Security through International Biosafety Norms (2016) (0)
- CONFRONTING B IOLOGICAL W EAPONS INVITED A RTICLE (2004) (0)
- Strategic Multilateral Dialogue on Biosecurity (2016) (0)
- Special section: Confronting biological weapons (2000) (0)
- Donald Ainslee Henderson, 1928-2016. (2016) (0)
- A World of Trouble. (2018) (0)
- Alterations in renal vascular resistance following coronary artery occlusion in dogs (1972) (0)
- Guidelines for treatment of anthrax. Authors' reply (2002) (0)
- Special issue on the global health security agenda. (2014) (0)
- Strengthen oversight of risky research on pathogens (2022) (0)
- LNG Imports Into North America and Implications (2008) (0)
- ST-Segment Elevation, Transient Left-Posterior Hemiblock, and Recurrent Ventricular Arrhythmias Unassociated with Pain (2020) (0)
- Management of potential bioterrorism-related conditions. (2015) (0)
- 1. NASEMSO Comments on Pandemic Influenza Vaccine Prioritization (2007) (0)
- RECOGNITION AND TREATMENT OF ANTHRAX. AUTHORS' REPLY (1999) (0)
- Head up designing with today’s technology (1998) (0)
- Essential Guidance for the Complex World of Biodefense (2014) (0)
- Bioterrorism: Guidelines for Medical and Public Health Management (2011) (0)
- Facing the biological weapons threat (2001) (0)
- Health security resolutions for 2014. (2013) (0)
- Health Management Smallpox as a Biological Weapon : Medical and Public (2000) (0)
This paper list is powered by the following services:
Other Resources About Tom Inglesby
What Schools Are Affiliated With Tom Inglesby?
Tom Inglesby is affiliated with the following schools: